Literature DB >> 16308313

DNA repair polymorphisms and cancer risk in non-smokers in a cohort study.

G Matullo1, A M Dunning, S Guarrera, C Baynes, S Polidoro, S Garte, H Autrup, C Malaveille, M Peluso, L Airoldi, F Veglia, E Gormally, G Hoek, M Krzyzanowski, K Overvad, O Raaschou-Nielsen, F Clavel-Chapelon, J Linseisen, H Boeing, A Trichopoulou, D Palli, V Krogh, R Tumino, S Panico, H B Bueno-De-Mesquita, P H Peeters, E Lund, G Pera, C Martinez, M Dorronsoro, A Barricarte, M J Tormo, J R Quiros, N E Day, T J Key, R Saracci, R Kaaks, E Riboli, P Vineis.   

Abstract

Environmental carcinogens contained in air pollution, such as polycyclic aromatic hydrocarbons, aromatic amines or N-nitroso compounds, predominantly form DNA adducts but can also generate interstrand cross-links and reactive oxygen species. If unrepaired, such lesions increase the risk of somatic mutations and cancer. Our study investigated the relationships between 22 polymorphisms (and their haplotypes) in 16 DNA repair genes belonging to different repair pathways in 1094 controls and 567 cancer cases (bladder cancer, 131; lung cancer, 134; oral-pharyngeal cancer, 41; laryngeal cancer, 47; leukaemia, 179; death from emphysema and chronic obstructive pulmonary disease, 84). The design was a case-control study nested within a prospective investigation. Among the many comparisons, few polymorphisms were associated with the diseases at the univariate analysis: XRCC1-399 Gln/Gln variant homozygotes [odds ratios (OR) = 2.20, 95% confidence intervals (CI) = 1.16-4.17] and XRCC3-241 Met/Met homozygotes (OR = 0.51, 95% CI = 0.27-0.96) and leukaemia. The recessive model in the stepwise multivariate analysis revealed a possible protective effect of XRCC1-399Gln/Gln in lung cancer (OR = 0.22, 95% CI = 0.05-0.98), and confirmed an opposite effect (OR = 2.47, 95% CI = 1.02-6.02) in the leukaemia group. Our results also suggest that the XPD/ERCC1-GAT haplotype may modulate leukaemia (OR = 1.28, 95% CI = 1.02-1.61), bladder cancer (OR = 1.38, 95% CI = 1.06-1.79) and possibly other cancer risks. Further investigations of the combined effects of polymorphisms within these DNA repair genes, smoking and other risk factors may help to clarify the influence of genetic variation in the carcinogenic process.

Entities:  

Mesh:

Year:  2005        PMID: 16308313     DOI: 10.1093/carcin/bgi280

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  108 in total

1.  APE1 Asp148Glu gene polymorphism and lung cancer risk: a meta-analysis.

Authors:  Ya-Nan Ji; Ping Zhan; Jing Wang; Li-Xin Qiu; Li-Ke Yu
Journal:  Mol Biol Rep       Date:  2010-12-04       Impact factor: 2.316

2.  XRCC1 gene polymorphisms and lung cancer susceptibility: a meta-analysis of 44 case-control studies.

Authors:  Liping Dai; Fujiao Duan; Peng Wang; Chunhua Song; Kaijuan Wang; Jianying Zhang
Journal:  Mol Biol Rep       Date:  2012-06-23       Impact factor: 2.316

3.  Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.

Authors:  Wenlong Zhai; Ruo Feng; Haiyu Wang; Yadong Wang
Journal:  Tumour Biol       Date:  2015-04-03

4.  DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy.

Authors:  Angeline S Andrew; Margaret R Karagas; Heather H Nelson; Simonetta Guarrera; Silvia Polidoro; Sara Gamberini; Carlotta Sacerdote; Jason H Moore; Karl T Kelsey; Eugene Demidenko; Paolo Vineis; Giuseppe Matullo
Journal:  Hum Hered       Date:  2007-09-26       Impact factor: 0.444

5.  The association of APE1 Asp148Glu gene polymorphisms and lung cancer risk: an updated meta-analysis.

Authors:  Wen Chen; Qin Wang; Mang Liu; Xiao-bing Ding
Journal:  Tumour Biol       Date:  2013-12-06

6.  XRCC1 Arg399Gln variation and leukemia susceptibility: evidence from 2,647 cases and 5,518 controls.

Authors:  Yi Huang; Denghai Xie; Nana Tang; Jishi Wang; Xiaoqing Zeng; Peng Zhao; Ling He
Journal:  Tumour Biol       Date:  2013-08-30

7.  Genetic polymorphisms of XRCC3 Thr241Met (C18067T, rs861539) and bladder cancer risk: a meta-analysis of 18 research studies.

Authors:  Qingtong Ma; Yumei Zhao; Shoufeng Wang; Xiaoyan Zhang; Jinling Zhang; Mei Du; Liang Li; Yun Zhang
Journal:  Tumour Biol       Date:  2013-10-02

8.  Association of XRCC1 genetic polymorphism (Arg399Gln) with laryngeal cancer: a meta-analysis based on 4,031 subjects.

Authors:  W Chen; Z Y Wang; F L Xu; K M Wu; Y Zhang; L Xu; Q P Wang
Journal:  Tumour Biol       Date:  2013-11-06

9.  XPD Lys751Gln polymorphism is not associated with oral cancer risk: evidence from a meta-analysis.

Authors:  Jing Cui; Dalu Li; Liang Shen; Wenmei Zhang; Xin Xu
Journal:  Tumour Biol       Date:  2014-03-22

10.  APE1 Asp148Glu polymorphism and lung cancer susceptibility.

Authors:  Liyun Cai; Yingjv Fu; Yuanyue Zhang
Journal:  Tumour Biol       Date:  2014-02-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.